Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years)

Journal of Hepatology

Volumn 46, Issue 1, 2007, Pages 19-25

  de Lédinghen, Victor ^a,b   Trimoulet, Pascale ^c   Mannant, Paul Régis ^d   Dumas, Francis ^e   Champbenoît, Patrick ^d   Baldit, Christian ^f   Foucher, Juliette ^a,g   Faure, Muriel ^c   Vergniol, Julien ^a   Castéra, Laurent ^a,g   Bertet, Julien ^a   Fleury, Hervé ^c   Couzigou, Patrice ^a   Bernard, Pierre Henri ^g  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL PELLEGRIN   (France)

^d Polyclinique Bordeaux Nord Aquitaine   (France)

^e Clinique du Tondu   (France)

^f CENTRE HOSPITALIER   (France)

^g HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Hepatitis C; Liver fibrosis; Natural history; Outbreak; Sclerotherapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DEMOGRAPHY; ELASTOGRAPHY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHYLOGENY; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROTHERAPY; SEQUENCE ANALYSIS; VARICOSIS; VIRUS GENOME; VIRUS TRANSMISSION;

ADULT; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; FOLLOW-UP STUDIES; FRANCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; SCLEROTHERAPY; TIME FACTORS; VARICOSE VEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 34447317106     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.07.029     Document Type: Article

References (26)

1. Sanchez-Tapias J.M. Nosocomial transmission of hepatitis C virus. J Hepatol 31 (1999) 107-112
2. de Lédinghen V., Trimoulet P., Cazajous G., Bernard P.H., Schrive M.H., Foucher J., et al. Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins. J Med Virol 76 (2005) 279-284
3. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irrish Hepatology Research Group. N Engl J Med 340 (1999) 1228-1233
4. Wiese M., Berr F., Lafrenz M., Porst H., and Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32 (2000) 91-96
5. Wiese M., Grüngreiff K., Güthoff W., Lafrenz M., Oesen U., and Porst H. East German hepatitis C study group. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol 43 (2005) 590-598
6. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology 24 (1996) 289-293
7. Castéra L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
8. Young K.K.Y., Resnick R.M., and Myers T.W. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 31 (1993) 882-886
9. Sandres-Sauné K., Deny P., Pasquier C., Thibaut V., Duverlie G., and Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109 (2003) 187-193
10. Mondelli M.U., and Silini E. Clinical significance of hepatitis C virus genotypes. J Hepatol 31 (1999) 65-70
11. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22 (1994) 4673-4680
12. Power J.P., Lawlor E., Davidson F., Holmes E.C., Yap P.L., and Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 345 (1995) 1211-1213
13. Simmonds P., Bukh J., Combet C., Deléage G., Enomoto N., Feinstone S., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
14. Evans R.J., and Spooner E.T.C. A possible mode of transfer of infection by syringes used for mass inoculation. BMJ 2 (1950) 462-466
15. Schiff R.I. Transmission of viral infections through intravenous immune globulin. N Engl J Med 331 (1994) 1649-1650
16. Gordon S.C., Elloway R.S., Long J.C., and Dmuchowski C.F. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology 18 (1993) 1338-1343
17. Vogt M., Lang T., Frosner G., Klingler C., Sendl A.F., Zeller A., et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implantation of blood-donor screening. N Engl J Med 341 (1999) 866-870
18. Rodger A.J., Roberts S., Lanigan A., Bowden S., Brown T., and Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971-1975. Hepatology 32 (2000) 582-587
19. Freeman A.J., Dore G.J., Low M.G., et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 34 (2001) 809-816
20. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C: the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 (1997) 825-832
21. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Schiffman M., Reindollar R., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358 (2001) 958-965
22. Fried M.W., Schiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., et al. Combination of peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
23. Hadziyannis S.J., and Sette Jr. H. Morgan TR peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of duration and ribavirin dose. Ann Intern Med 140 (2004) 346-355
24. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Non-invasive assessment of liver fibrosis by stiffness measurement: a prospective multicentre study in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
25. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
26. Smith D., and Simmonds P. Review: molecular epidemiology of hepatitis C virus. J Gastroenterol Hepatol 12 (1997) 522-527